Point of Care Molecular Diagnostics Market Growth 2023

PUNE, MAHARASHTRA, INDIA, May 31, 2018 /EINPresswire.com/ -- Global Point of Care Molecular Diagnostic Market Report 2023," offers a comprehensive understanding of the topic. is poised to witness robust growth over the forecast period. Increasing infectious diseases incidence coupled with growing public awareness levels pertaining to pre-disease detection to control its occurrence will drive PoC molecular diagnostics market growth. Quick and precise detection of causative agents is of utmost importance in infectious disease emergency cases as the inaccuracy in disease detection leads to incorrect treatment which escalates disease spreading risk. Point of care molecular diagnostic assays permit the timely detection of the causative agent enabling effective disease control.

Get a Sample PDF for Research Insights at: https://www.healthcareintelligencemarkets.com/request_sample.php?id=28543

Global point of care (POC) molecular diagnostics market is expected to reach USD +1439 Million by 2023 from USD +724 Million in 2018, at a CAGR of +13%

The healthcare industry recognizes medical devices as all equipment and tools that are used either individually or together for diagnostics or therapy. This spectrum includes medical instruments, materials, devices, software, and electronic devices. The competitive landscape of the global Point of Care Molecular Diagnostic market is currently hinged around the top players. Most of the players are focusing heavily on enhancement of existing technologies while still dedicating a huge chunk of their resources for product innovation. The nature of the market is such that entry for newer players can be challenging, but not impossible due to the desperate need for newer technologies and innovative patents in the market.

Some of the leading vendors: Roche Diagnostics (Switzerland), Biomerieux (France), Danaher (US), Abbott Laboratories (US), Quidel (US) and Meridian Bioscience (US).

Report studies the market for Point of Care Molecular Diagnostic from a global perspective while also analyzing it for key regional markets, including North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. On these fronts, the market is analyzed on the basis of criteria such as market value, key segments, market volume, and distribution channels.

Avail Discount on this report: https://www.healthcareintelligencemarkets.com/ask_for_discount.php?id=28543

Polymerase Chain Reaction (PCR) technology held the largest share in 2016 and is slated to witness rapid growth over the coming years owing to its extended application and improved precision and reproducibility. Growing incidence of infectious disease and genetic disorders coupled with increase in public-private investment in PCR oriented research will propel segment growth.Chips and microarrays will witness significant growth during the forecast period as they are at the forefront of the ongoing revolution in life science and molecular biology.

Table of Content:

Chapter 1 Point of Care Molecular Diagnostic Market Overview
Chapter 2 Global Economic Impact on Industry
Chapter 3 Global Market Competition by Manufacturers
Chapter 4 Global Production, Revenue (Value) by Region
Chapter 5 Global Supply (Production), Consumption, Export, Import by Regions
Chapter 6 Global Production, Revenue (Value), Price Trend by Type
Chapter 7 Global Market Analysis by Application
Chapter 8 Manufacturing Cost Analysis
Chapter 9 Industrial Chain, Sourcing Strategy and Downstream Buyers
Chapter 10 Marketing Strategy Analysis, Distributors/Traders
Chapter 11 Market Effect Factors Analysis

Shreyas Tanna
Healthcare Intelligence Markets
+91 7400242424
email us here